银河医药混合C(015666)资产配置
| 序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
| 1 |
2025-03-31 |
92.86 |
- |
5.69 |
496,542,982.25 |
| 2 |
2024-12-31 |
94.24 |
- |
6.02 |
484,067,188.06 |
| 3 |
2024-09-30 |
93.05 |
- |
5.61 |
537,324,482.63 |
| 4 |
2024-06-30 |
93.04 |
- |
7.21 |
471,545,261.30 |
| 5 |
2024-03-31 |
93.21 |
- |
6.98 |
504,087,980.25 |
| 6 |
2023-12-31 |
94.20 |
- |
6.01 |
602,713,994.13 |
| 7 |
2023-09-30 |
94.17 |
- |
5.97 |
631,487,575.03 |
| 8 |
2023-06-30 |
94.03 |
- |
7.10 |
697,402,187.80 |
| 9 |
2023-03-31 |
94.10 |
- |
6.23 |
785,801,204.03 |
| 10 |
2022-12-31 |
92.65 |
- |
8.01 |
819,558,697.31 |
| 11 |
2022-09-30 |
94.19 |
- |
5.98 |
755,653,130.86 |
| 12 |
2022-06-30 |
93.77 |
- |
6.13 |
899,281,470.60 |
欢迎访问证券之星！请点此与我们联系 版权所有： Copyright © 1996-年
微信公众号
证券之星APP
基本资料
